Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 10, Issue 9, Pages 1407-1418
Publisher
Informa UK Limited
Online
2010-09-13
DOI
10.1586/era.10.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- XmAb5574: In vitro and in vivo efficacy of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia and its effect on B cells in non-human primates
- (2017) E. Zhukovsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting SYK kinase-dependent anti-apoptotic resistance pathway in B-lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic
- (2010) Fatih M. Uckun et al. BRITISH JOURNAL OF HAEMATOLOGY
- Activities of SYK and PLC 2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib
- (2010) Z. Song et al. CLINICAL CANCER RESEARCH
- Targeting and internalization of sterically stabilized liposome modified with ZCH-4-2E8
- (2010) Jingying Zhang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress
- (2010) F. M. Uckun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia
- (2009) Roman Crazzolara et al. Autophagy
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Polo-like-kinase 1 (PLK1) as a molecular target to overcome SYK-mediated resistance of B-lineage acute lymphoblastic leukaemia cells to oxidative stress
- (2009) Fatih M. Uckun et al. BRITISH JOURNAL OF HAEMATOLOGY
- Proteomic and Genetic Approaches Identify Syk as an AML Target
- (2009) Cynthia K. Hahn et al. CANCER CELL
- Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
- (2009) Maike Buchner et al. CANCER RESEARCH
- Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes
- (2009) Armando G. Villaseñor et al. Chemical Biology & Drug Design
- Therapeutic prospect of Syk inhibitors
- (2009) Paolo Ruzza et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression
- (2009) A D Baudot et al. ONCOGENE
- Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework
- (2009) Markus Kügler et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A novel Syk family kinase inhibitor: Design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives
- (2008) Akihito Hirabayashi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response
- (2008) E. Marston et al. BLOOD
- Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
- (2008) R. M. Young et al. BLOOD
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors
- (2008) Kevin M. Dennehy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bone-marrow relapse in paediatric acute lymphoblastic leukaemia
- (2008) L Charles Bailey et al. LANCET ONCOLOGY
- Ten-year survival of children with acute lymphoblastic leukemia: A report from the Children's Oncology Group
- (2008) Michael E. Trigg et al. LEUKEMIA & LYMPHOMA
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Treatment of Childhood Acute Lymphoblastic Leukemia
- (2008) Martin Stanulla et al. SEMINARS IN HEMATOLOGY
- A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers
- (2008) Kun Yu et al. PLoS Genetics
- The microtubule-associated protein tau is phosphorylated by Syk
- (2007) Thibaud Lebouvier et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab′ fragments and single chain Fv
- (2007) Wilson W.K. Cheng et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started